Dean Joyner Email & Phone Number

Layton, Ut, Us

Research Triangle Park, Nc, Us

Seal Beach , Ca, Us

Currently promote Provenge the first Immunotherapy indicated for men with Hormone Resistant Metastatic Prostate Cancer. A novel therapy in the fight against Prostate Cancer

Tokyo, Jp

Responsible for the Sales and Marketing of Natpara for patients with Hypoparathyroidism. Call point is Endocrinologists, Otolaryngologists, and Nephrologists2 time MVP award nominated by Peer's

South San Francisco, Ca, Us

Responsible for the sales & Marketing of Afirma, a Genomic Sequencing Classifier to reduce unnecessary thyroid surgeries. High-Level clinical sale to Endocrinologists, ENT's, Clinical Pathologists & Physician communities by resolving diagnostic uncertainty regarding thyroid cancerTerritory management included Utah, Idaho, Montana and Wyoming. Quick impact in territory due to strategic business planning and identifying high impact accountsEstablished a KOP and held 3 speaking programs in 4 monthsTook a 43rd out of 43rd ranked territory to #3 in the nation in 6 months.

San Diego, Ca, Us

• Launch and introduce a novel thermo-sensitive liquid-to-gel technology, a Ciprofloxacin Otic suspension for Tympanostomy tube placement, as well as a new company into the Northwest Region market.• 2016 President’s Club Award winner.• Nominated as one of 4 representatives in the nation to attend a “Think-Tank” retreat. This was to generate & promote innovative ideas to help the commercial organization move forward. • Collaborate with “Thought Leaders” to establish and develop business plans for a successful launch and introduction of Otiprio into the community ENT Physicians.• Gained formulary acceptance within Intermountain Healthcare System, one of the largest IDN’s within the first year of launch. Two – three years is the standard time to gain formulary acceptance with this IDN, when you have no history or prior products on formulary with them. • Thorough understanding of the launch process while working as a National Accounts Representative in addition to sales duties. Created work order sets and quality flow. From the process of physician order, through supply chain, stocking Otiprio, and follow through with billing and reimbursement of product. Pulled through the C-codes that billers have little experience with, in order for the system to not sustain a financial loss. • Finished in the top 10% of sales, prior to Otiprio orders from Intermountain and project myself as #1 by end of the 2017 year with pull through efforts and plans within this IDN.• Territory includes Utah, Nevada, Idaho, Montana, Wyoming, Nebraska and parts of North & South Dakota.

Sant Cugat Del Vallès, Barcelona, Es

• Responsible for the sales and promotion of Prolastin C indicated for patients with Alpha-1 Antitrypsin deficiency, a DNA based lung disease.• Pulmonary Sales Advisory Board - Worked with Dan Beltrani for ideas and implementation of strategic marketing material for the 2013 year.• Market Development Team – Working with Michael Spada to create and implement ideas for emerging markets, such as EMR implementation, PQRI and Meaning Use requirements, along with developing a work flow chart to be used by all representatives in the Pulmonary Division to standardize selling processes across the teams.• Presidents Club Award Winner x3.• Created & lead Innovation Team that presented new forward thinking ideas to Grifols Executives to help train, develop and promote products, strengthen brand equity & increase commercial revenue. Presentation was successful as ALL ideas were immediately implemented in the North American Region.• Successfully completed 17 speaker programs for 2012 with strategic focus based on the implementation of each program.• Converted a large pulmonary practice in Las Vegas, (5 offices), to implement a testing protocol based on the ATS guidelines, standardizing on Prolastin C as the therapy of choice.• Received 15 referrals for 2013, meeting and exceeding 8 referral quota. Ranked 7th in the nation out of 134, receiving an “Outstanding” on performance review for 2013.• Received 15 referrals for 2014, meeting and exceeding 8 referral quota. Review 3rd in the nation out of 134 with an “Outstanding” on performance review for 2014.• Started 2015 by obtaining 4 referrals in the first 2 weeks of January. Ended with 22 and ranked 3rd in the Nation. Left to Otonomy before reviews given following VP of Sales and Regional Sales Manager from Grifols.• Establish and maintain key relationships with top physicians in the industry ie., Dr Hogarth, Dr Miskoff & Dr.Walia.

Research Triangle Park, Nc, Us

*NOTE: Purchased by Grifols• Responsible for the sales and promotion of Gamunex a unique and novel IVIG Infusion for multiple therapeutic options. • HyperImmunes. • Work with Channel Partners and Specialty Pharmacies to generate pull through of Gamunex into the Hospitals as well as Community Infusion Suites.• Currently at 94% to plan for Gamunex and 227% percent to plan for the Hyperimmunes.• The Main call Points are Hospital Pharmacy Directors, Buyers or Purchasers, Medical Neurologists, Oncologists and Allergists.• Achieved Success by driving business out of Hospitals that are Gamunex challenged and by driving business into hospitals that are Gamunex friendly.• Converted 9 Infusion suites throughout the Utah, Idaho and Montana to Gamunex by partnering with a Channel Group and selling the clinical benefits of Gamunex and moving the IVIG away from a commodity market.

Cambridge, Cambridgeshire, Gb

• Responsible for the sales and promotion of : - Arimidex & Faslodex (injectable) for the treatment of Breast Cancer.- Casodex & Zoladex (an LHRH Injection) for the treatment of Prostate Cancer.• Achieved and Exceeded sales goals for 2007 by achieving 168-278% of quota for Breast and Prostate Cancer products.• Recognized as one of the Top 8 Oncology Reps in the Nation for 2007 out of 134.• Recognized as one of the Top 5 Oncology Reps in the Nation for 2006 out of 134.• Recognized as one of the Top 7 Oncology Reps in the Nation for 2005 out of 143.• Established, maintained and developed relationships with Medical Oncologists within the Montana, Idaho, and Utah territories.• Developed the ability to create awareness, build market share and generate revenue through programs with key speakers who have been identified as leaders in their field.• Cross Regional Training Initiative: Developed and implemented a program that allowed 10 year representatives the opportunity to observe different selling techniques and share best practices within their regions. Consequently maximizing market share and creating selling opportunities.• Women in Cancer Initiative: Created a women’s networking group to showcase the strength and power of female collaboration for a common purpose, emphasizing patient health first. Grouped leading women Oncologists in the Rocky Mountain Area together, discussing patient needs, and improving overall communication and cohesiveness within this arena.ADVANCED SALES TRAINER• Identified as one of the top 10 Oncology reps in the Nation to attend a specialized and advanced training course. • Developed as a Train the Trainer Program to take back and educate the field on the “Customer Centric Selling” model and how to “Think like a physician” sales approach.In addition to:• DISTRICT TRAINING CHAMPION • NATIONAL SALES DELEGATE• BUSINESS ACUMEN CHAMPION• TOUCHSTONE SUITE CHAMPION

Cambridge, Cambridgeshire, Gb

• Responsible for the sales & promotion of respiratory products including: Pulmicort Turbuhalor, Pulmicort Respules and Rhinocort Aqua to key Family Practice Physicians, Pulmonologists, Allergists, Otolaryngologist and Pediatricians in the Northern Utah Territory. • Hands on experience through surgical preceptorships with leading Otolaryngologists. • Pulmonary Training Champion: Lead training within the Ogden, Utah cylinder and supporting the training initiative laid out by the regional office for the pre-launch activities of Crestor. • National Convention Delegate: Attended AAP meeting in San Francisco, CA. Presented respiratory products to numerous physicians and received high recognition by Scott Tutak, the Professional Relations and Education Manager for AstraZeneca, as being one of the top contributors to the meeting.• Prior Responsibilities to the merger of Astra and Zeneca was for the promotion of Zomig to Neurologists, Major Hospitals (i.e. University of Utah) and Pain clinics along the Wasatch front. During the launch phase Zomig was 8th in the Nation and held a 23% NRX Market share at the University of Utah and associated pain clinics. • Started as a Cardiovascular representative with responsibilities for Tenormin, Zestoril and Sular.